EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research

REDWOOD CITY, Calif.–(BUSINESS WIRE)– #AutoimmuneResearch–The addition of Knockout CD4+ T-cell Pools to EditCo Bio’s product lineup marks a significant leap forward in CRISPR-mediated gene editing.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks